Zyprexa was 1st patented in copyright in 1980. Eli Lilly acquired a patent extension in 1991 on the bottom that it experienced observed new uses for that drug. In 2009, the Canadian Federal Courtroom invalidated the patent extension dependant on a acquiring which the drug allegedly had not sent the promised utility.In January 2011, after protracted